Showing results (21-30 of 103) with videos related to
Sort By:
Pageof 11
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 23, 2008
Phase I-II trial of bortezomib plus oral cyclophosphamide and prednisone in relapsed and refractory multiple myelomaDonna E Reece, Giovanni Piza Rodriguez, Christine Chen, et al.Journal of Proteome Research|March 9, 2010
Measurement of protein phosphorylation stoichiometry by selected reaction monitoring mass spectrometryLily L Jin, Jiefei Tong, Amol Prakash, et al.Clinical Lymphoma, Myeloma & Leukemia|June 29, 2016
Cyclophosphamide and Bortezomib With Prednisone or Dexamethasone for the Treatment of Relapsed and Refractory Multiple MyelomaDonna E Reece, Young Trieu, Esther Masih-Khan, et al.Molecular & Cellular Proteomics : MCP|January 15, 2015
Tyrosine phosphorylation of the Lyn Src homology 2 (SH2) domain modulates its binding affinity and specificityLily L Jin, Leanne E Wybenga-Groot, Jiefei Tong, et al.Leukemia & Lymphoma|April 18, 2014
Intermittent granulocyte colony-stimulating factor for neutropenia management in patients with relapsed or refractory multiple myeloma treated with lenalidomide plus dexamethasoneHaowei Linda Sun, Eshetu G Atenafu, Elizabeth Yeboah, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|November 9, 2011
Second autologous stem cell transplantation as salvage therapy for multiple myeloma: impact on progression-free and overall survivalVictor H Jimenez-Zepeda, Joseph Mikhael, Andrew Winter, et al.Cancer Medicine|November 19, 2016
Secondary primary malignancies during the lenalidomide-dexamethasone regimen in relapsed/refractory multiple myeloma patientsRouslan Kotchetkov, Esther Masih-Khan, Chia-Min Chu, et al.Proteomics|October 15, 2014
Differential regulation of FGFR3 by PTPN1 and PTPN2Jonathan R St-Germain, Paul Taylor, Wen Zhang, et al.European Journal of Haematology|November 12, 2021
Kinetics of response to first- and second-line therapies in multiple myeloma: Assessment by both M-spikes and light chainsEyal Lebel, Xuan Li, Harminder Paul, et al.Cold Spring Harbor Molecular Case Studies|January 13, 2023
Single-cell profiling of multiple myeloma reveals molecular response to FGFR3 inhibitor despite clinical progressionDanielle C Croucher, Anup Joseph Devasia, Dor D Abelman, et al.Pageof 11